Infectious Disease & Vaccines
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 MRK | Merck & Co., Inc. | $292.0b | $120.57 | -0.3% | 1.4M |
 GILD | Gilead Sciences Inc | $169.2b | $139.59 | -0.1% | 558.5K |
 PFE | Pfizer Inc. | $158.0b | $28.09 | -0.8% | 6.7M |
 MRNA | Moderna, Inc. Common Stock | $19.1b | $48.63 | -1.1% | 1.0M |
 SMMT | Summit Therapeutics Inc. Common Stock | $13.2b | $19.23 | -0.8% | 531.5K |
 PCVX | Vaxcyte, Inc. Common Stock | $7.9b | $57.92 | -0.8% | 175.4K |
 BCRX | BioCryst Pharmaceuticals Inc | $2.4b | $9.46 | +4.8% | 776.3K |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.4b | $9.09 | +0.3% | 250.6K |
 NVAX | Novavax Inc | $1.3b | $8.04 | +4.5% | 1.2M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.8b | $4.53 | +1.0% | 207.2K |
 CRMD | CorMedix Inc. | $0.5b | $7.13 | +1.1% | 201.5K |
 ASMB | Assembly Biosciences, Inc | $422.6m | $29.43 | +1.4% | 45.4K |
 EBS | Emergent Biosolutions, Inc. | $415.7m | $8.31 | +1.0% | 76.8K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $404.7m | $5.88 | +2.0% | 123.9K |
 SIGA | SIGA Technologies Inc. | $376.8m | $5.13 | -2.0% | 356.3K |
 ENTA | Enanta Pharmaceuticals, Inc | $353.5m | $13.51 | +2.8% | 21.6K |
 IVVD | Invivyd, Inc. Common Stock | $336.3m | $1.34 | +5.1% | 1.2M |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $314.7m | $11.48 | +12.8% | 27.3K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $196.1m | $8.37 | +4.2% | 149.8K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $161.3m | $14.02 | +0.9% | 87.8K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $129.7m | $2.57 | +5.6% | 260.0K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $124.4m | $3.35 | +2.4% | 116.0K |
 INO | Inovio Pharmaceuticals, Inc. | $115.4m | $1.13 | -0.4% | 2.1M |
 MCRB | Seres Therapeutics, Inc. | $84.4m | $9.16 | -1.1% | 9.6K |
 XBIT | XBiotech Inc | $69.2m | $2.37 | +1.0% | 5.4K |
 IBO | Impact BioMedical, Inc. | $63.1m | $0.62 | +4.5% | 88.5K |
 ZTEK | Zentek Ltd. Common Stock | $55.4m | $0.54 | +1.6% | 17.0K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $40.6m | $8.38 | +5.1% | 12.5K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $40.6m | $5.15 | -4.1% | 13.6K |
 SCYX | SCYNEXIS, Inc. | $35.3m | $0.93 | +4.5% | 220.3K |
 NNVC | NanoViricides Inc. | $18.8m | $1.00 | +7.6% | 64.8K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $4.62 | +3.5% | 9.6K |
 TRAW | Traws Pharma, Inc. Common Stock | $14.0m | $1.62 | -1.2% | 20.9K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $13.8m | $1.41 | -6.6% | 2.6M |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $12.4m | $11.89 | -1.6% | 12.4K |
 MBRX | Moleculin Biotech, Inc. | $12.0m | $2.29 | -1.5% | 14.3K |
 SNGX | Soligenix, Inc. Common Stock | $11.2m | $1.14 | 0.0% | 72.8K |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $10.0m | $3.66 | -0.7% | 19.7K |
 IMNN | Imunon, Inc. Common Stock | $9.8m | $3.15 | -2.3% | 12.1K |
 PHGE | BiomX Inc. | $7.2m | $3.29 | -10.1% | 67.8K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.8m | $0.92 | -1.1% | 3.4K |
 XBIO | Xenetic Biosciences, Inc. | $6.1m | $2.99 | -0.6% | 2.5K |
 SBFM | Sunshine Biopharma Inc. | $5.0m | $1.06 | +1.9% | 14.8K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $3.7m | $1.90 | +1.9% | 59.8K |
 CODX | Co-Diagnostics, Inc. Common Stock | $3.6m | $1.57 | +1.9% | 54.9K |
 AEMD | AETHLON MEDICAL INC | $3.3m | $2.14 | +0.9% | 2.4K |
 GOVX | GeoVax Labs, Inc. New | $3.0m | $1.27 | -4.8% | 33.3K |
 AIM | AIM ImmunoTech Inc. | $2.3m | $0.60 | +1.2% | 79.8K |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $1.2m | $0.16 | -9.8% | 770.4K |